Erectile dysfunction. N52.9
Conditions
Interventions
Intervention 1: Intervention group: Taking 30 ml of blood from the patient to receive platelet-rich plasma by centrifugation through a standard device, injecting 6 cc of platelet-rich plasma received
Sponsors
Guilan University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
30 Years to 60 Years
Inclusion criteria
Inclusion criteria: Non-responder to PDE5Is Having score at least 21 in IIEF questionnair More than 6 months have passed since erectile dysfunction Have at least 10 years of diabets history Having persistent sex in last 3 months
Exclusion criteria
Exclusion criteria: History of using PDE5Is in the last month History of psychological disorders and use of related drugs for its treatment History ofusing energy therapy for erectile dysfunction in the last month History of radiation or penile surgery or having penile prosthesis History of trauma, fracture and pelvic surgery History of priapism, penile fracture and Peyronie's History of using anti-androgen and selective serotonin reuptake inhibitors (SSRIs) Presence of active infection evidence in the injected area Abnormal morning testosterone levels (lower than 200 and above 1197)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Erectile function. Timepoint: Before intervention, 1, 3 and 6 months after last injection. Method of measurement: The International Index of Erectile Dysfunction (IIEF) questionnaire.;Erection quality. Timepoint: Before intervention, 1, 3 and 6 months after last injection. Method of measurement: Erectile Hardness Score (EHS) index. | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient satisfaction score of treatment. Timepoint: 1, 3 and 6 months after last injection. Method of measurement: Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAmir Hossein Shahabi
Urology Research Center, Guilan University of Medical Sciences
Outcome results
None listed